Daewoong Pharmaceutical said Monday that it has signed an exclusive license agreement with UAE-based Zydus Worldwide DMCC, a wholly owned subsidiary of Zydus Lifesciences headquartered in India, to co-develop and commercialize leuprolide acetate for depot suspension, DWJ108U, in the U.S. (Credit...